Cargando…
The clinical utility of gene testing for Alzheimer's disease
Alzheimer's disease (AD) is the largest cause of dementia, affecting 35.6 million people in 2010. Amyloid precursor protein, presenilin 1 and presenilin 2 mutations are known to cause familial early-onset AD, whereas apolipoprotein E (APOE) ε4 is a susceptibility gene for late-onset AD. The gen...
Autores principales: | Atkins, Emily R., Panegyres, Peter K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141112/ https://www.ncbi.nlm.nih.gov/pubmed/21785673 http://dx.doi.org/10.4081/ni.2011.e1 |
Ejemplares similares
-
Brain Amyloid in Sporadic Young Onset Alzheimer’s Disease
por: Panegyres, Peter K., et al.
Publicado: (2023) -
The natural history of early-onset dementia: the Artemis Project
por: Atkins, Emily R, et al.
Publicado: (2012) -
The Clinical Spectrum of Young Onset Dementia Points to Its Stochastic Origins
por: Panegyres, Peter K.
Publicado: (2021) -
The clinical differentiation of fronto-temporal dementia from psychiatric disease
por: Panegyres, Peter K, et al.
Publicado: (2007) -
Prion diseases: immunotargets and therapy
por: Burchell, Jennifer T, et al.
Publicado: (2016)